Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: m


Summaries of Product Characteristics 1 - 30 of 297
  1  2  3  4  5  6  7  8  9  10  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
M-M-RVAXPRO - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
MabThera - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Macimorelin Aeterna Zentaris - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Madopar 100 mg-25 mg depotkapseli SPC 2022-01-04 Uusi

PL

Resepti

Madopar 100 mg-25 mg, 200 mg-50 mg tablettti SPC 2022-01-04 Uusi

PL

Resepti

Madopar Quick 100 mg-25 mg liukeneva tabletti SPC 2022-01-04 Uusi

PL

Itsehoito

Magnesiamaito 82,5 mg-ml oraalisuspensio SPC 2021-06-08

PL

Itsehoito

Magnesium Diasporal 400 mg jauhe oraaliliuosta varten SPC 2018-07-19

PL

Itsehoito

Magnesium Diasporal 400 mg rakeet SPC 2020-11-24

PL

Resepti

MaitalonCont 0,02 mg- 3 mg tabletti, kalvopäällysteinen SPC 2017-12-04.doc

PL

Itsehoito

Makrogoli Orion 12 g jauhe oraaliliuosta varten, annospussi SPC 2021-08-18

PL

Itsehoito

Makrogoli Orion 6 g jauhe oraaliliuosta varten, annospussi SPC 2021-08-18

PL

Resepti

Malarone 250 mg- 100 mg tabletti, kalvopäällysteinen SPC 2021-10-25

PL

Itsehoito

Maltofer 100 mg Fe+++ purutabletti SPC 2021-04-28

PL

Itsehoito

Maltofer 50 mg Fe+++ -ml tipat, liuos SPC 2022-03-24

PL

Itsehoito

Malvitona oraaliliuos SPC 2021-10-01

PL

Resepti

Mannitol Baxter Viaflo150 mg-ml, infuusioneste SPC 2021-09-06

PL

Resepti

Mannitol Braun 150 mg-ml infuusioneste SPC 2020-03-13

PL

Resepti

Marbodin 10 mg tabletti, kalvopäällysteinen SPC 2021-05-14

PL

Resepti

Marbodin 20 mg tabletti, kalvopäällysteinen SPC 2021-05-14

PL

Resepti

Marcain Adrenalin 2.5 mg-ml+5 mikrog-ml, 5 mg-ml+5 mikrog-ml injektioneste, SPC 2022-01-28

PL

Resepti

Marevan 3 mg, 5 mg tabletti SPC 2021-11-11

PL

Resepti

Marevan 3 mg, 5 mg tabletti SPC 2021-11-11

European Medicines Agency's website:
Marixino (ent. Maruxa) - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Marzine 50 mg tabletti SPC 2021-11-02

European Medicines Agency's website:
Matever - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Matrifen 12, 25, 50, 75, 100 mikrog-tunti depotlaastari SPC 2022-02-22.doc

European Medicines Agency's website:
Mavenclad - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Maviret - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Maxalt 5 mg, 10 mg tabletti SPC 2021-04-27

  1  2  3  4  5  6  7  8  9  10  |  Next 30   >